Enterotoxigenic Bacteroides fragilis was isolated from stool specimens of 8 of 44 diarrheic individuals (ages, 4 months to 69 years). The individuals had watery diarrhea and intestinal cramping; and infants had hyperthermia, vomiting, and blood in the stools. No recognized enteric pathogens were detected in seven of the eight diarrheic individuals positive for enterotoxigenic B. fragilis. The bacterium produced an enterotoxin detectable in concentrated broth that supported bacterial growth. Fifteen adult rabbits with ligated ceca developed fatal enteric disease following intraileal injection with 5 x 109 CFU of enterotoxigenic B. fragilis. Conversely, eight control rabbits injected with nonenterotoxigenic B. fragilis remained clinically normal. As few as 5 x 103 CFU of enterotoxigenic B. fragilis caused fatal enteric disease in the rabbit model. Disease in rabbits was characterized by mucoid, often hemorrhagic, diarrhea. The bacterium colonized the caudal small intestine and the colon of the rabbits and caused moderate to severe necrotizing colitis. Enterotoxigenic B. fragilis is widespread in the intestinal tract of diarrheic humans and is enteropathogenic in adult rabbits with ligated ceca. Its possible role in the enteric disease complex merits further study.
Bacteroides fragilis is a gram-negative, non-sporeforming, obligately anaerobic bacterium found in high numbers in the intestinal tracts of humans and animals. The bacterium is recognized as an important cause of abscesses and other extraintestinal infections in various tissues in humans but is not recognized as an enteric pathogen in humans.
While most intestinal isolates of B. fragilis are nonenterotoxigenic, it has been shown (8) that some animal isolates elaborated an enterotoxin into the medium during growth in vitro. Enterotoxin activity was detected in concentrated (but not in unconcentrated) broth by using the calf or lamb ligated ileal loop (LIL) test. Enterotoxigenic B. fragilis has been isolated from the feces of diarrheic lambs (5), calves (8) , pigs (7) , and foals (L. L. Myers, D. S. Shoop, and T. D. Byars, Am. J. Vet. Res., in press). Severe enteric disease occurred in adult rabbits with ligated ceca following intraileal injection of 5 x 109 CFU of one of three different porcine isolates of enterotoxigenic B. fragilis (7) . In the present study, it is shown that enterotoxigenic B. fragilis can also be isolated from diarrheic humans and that human isolates of enterotoxigenic B. fragilis are virulent in the adult rabbit model.
MATERIALS AND METHODS
Isolation of B. fragilis. Seventy-six stool specimens from 44 diarrheic individuals were obtained by using rectal swabs (Culturette II; Marion Scientific, Div. Marion Laboratories, Inc., Kansas City, Mo. brain heart infusion broth for 48 h. Formalin was added (0.3%), and the cell suspensions were centrifuged at 12,000 x g for 20 min. The supernatant fluids were passaged at 4°C through a filter (molecular weight cutoff, 10,000; PM-10; Amicon Corp., Danvers, Mass.) to a retentate volume of 30 to 40 ml. The retentates were centrifuged (12,000 x g for 20 min), passed through a filter (pore size, 0 Rabbit studies. Brain heart infusion broth culture of B.
fragilis (1 ml; 5 x 109 CFU) was injected directly into the ileum of a 1.8-to 2.2-kg New Zealand White rabbit in which the cecum had been ligated as described previously (11) . A total of 15 rabbits were injected with one of two isolates of enterotoxigenic B. fragilis, and 8 rabbits were injected with one of two isolates of nonenterotoxigenic B. fragilis (see Table 2 ). A dose-response study was also done with 22 rabbits (see Table 3 ). In this study, 10-fold dilutions of a brain heart infusion broth culture of isolate 2-078382-3 were made. The number of CFUs was determined by plating appropriate dilutions of the challenge inoculum onto TBA plates. Rabbits were observed for clinical signs of enteric disease for 6 days postchallenge (p.c.). Tissues for histopathological examination were collected from five additional rabbits with ligated ceca that had been injected with 5 x 109 CFU of enterotoxigenic B. fragilis (isolates 2-078382-3, 20793-3, 20656-2-1) or with nonenterotoxigenic B. fragilis (isolates 20662 or 20669). The rabbits were euthanized 2 to 3 days p.c., and tissues were taken from three areas of the small intestine (5 cm from the cranial end of the duodenum, mid-jejunum, and 5 cm proximal from the caudal end of the ileum) and two areas of the colon (10 cm distal from the ileocecal junction and the rectum (1 to 1.5 ml of fluid per cm of intestine) being at approximately fraction 79 (elution volume, 237 ml). By using either broth retentates or viable cells in the lamb LIL test, the accumulated fluid was cloudy, and a pseudomembrane formed which was composed primarily of fibrin and leukocytes.
Rabbit studies. The 15 rabbits injected into the ileum with enterotoxigenic B. fragilis developed enteric disease and died by 5 days p.c. (7 rabbits died 2 to 3 days p.c.), whereas the 8 rabbits given nonenterotoxigenic B. fragilis remained clinically normal (Table 2) . Diarrhea (feces not pelleted) commonly occurred by 24 h p.c. in the rabbits. As the disease progressed, the feces became more mucoid and watery and often contained frank blood. Enterotoxigenic B. fragilis was isolated from the distal 30 cm (but not from the proximal 30 cm) of the small intestine and from the entire length of the colon in diarrheic rabbits. The duodenum and jejunum were normal histologically, whereas mild enteritis was observed in the ileum of infected rabbits. Moderate to severe necrotizing colitis was characteristic of diarrheic rabbits (Fig. 2) . Nonenterotoxigenic B. fragilis was isolated from the ileum and colon of a rabbit inoculated with nonenterotoxigenic B. fragilis, and no intestinal lesions were detected. In the dose-response study (Table 3) , as few as 5 x 103 CFU of enterotoxigenic B. fragilis caused fatal enteric disease. As the challenge dose was increased, the incidence of enteric disease increased. Nonfatal enteric disease was not observed. DISCUSSION Although enterotoxigenic B. fragilis has been isolated from the feces of several species of young, diarrheic livestock, this is the initial report of its isolation from diarrheic humans and of data indicating that human isolates of enterotoxigenic B. fragilis are enteropathogenic in an animal model. The bacterium was isolated from eight diarrheic individuals of widely different ages, and in seven of the eight individuals, recognized enteric pathogens were not detected. Diarrhea associated with enterotoxigenic B. fragilis was watery and usually of 1 to 4 weeks in duration.
Enterotoxigenic isolates of B. fragilis were highly virulent in the adult rabbit with ligated cecum, whereas isolates of nonenterotoxigenic B. fragilis were avirulent. In addition to the human isolates studied, we also evaluated 20 animal isolates of enterotoxigenic B. fragiiis and 10 animal isolates of nonenterotoxigenic B. fragilis in rabbits. In all cases, the isolates of enterotoxigenic B. fragilis caused diarrhea (some apparently more so than others), and the nonenterotoxigenic B. fragilis isolates were avirulent (7; Myers, et al., in press; fragilis has a predilection for the colon, reversible ligation of the ileum would not appear to be indicated.
Enterotoxigenic B. fragilis elaborated a heat-labile enterotoxin into the broth during growth. Enterotoxin activity was also detected in the eluant buffer following gel filtration of broth retentates on Sephadex G-75. While the molecular weight of the enterotoxin was not determined in this study, in an earlier report (8) it was indicated that enterotoxin from a bovine isolate of enterotoxigenic B. fragilis had an apparent molecular weight of 19,500, as determined by Sephadex G-100 chromatography. Results of preliminary studies (5) have indicated that enterotoxin activity of bovine isolates of enterotoxigenic B. fragilis was not detectable in the infant mouse gastric test, the Y-1 mouse adrenal tumor cell assay, or in a gene probe assay for E. coli and V. cholerae enterotoxin. These negative results were obtained with viable cells of enterotoxigenic B. fragilis and with unconcentrated broth filtrates. In a recent study (unpublished data), we were also unable to satisfactorily detect the enterotoxin using broth retentates and viable cells in the rabbit ileal loop test. The enterotoxin appeared to cause fluid accumulation in some rabbits but not in others.
As is true of the established enteropathogens, we recently found that enterotoxigenic B. fragilis could be isolated from clinically normal individuals. In an ongoing study, enterotoxigenic B. fragilis thus far has been isolated from the feces of 19 of 123 (15.4%) diarrheic individuals and from 6 of 83 (7.2%) nondiarrheic, matched controls (unpublished data). Enterotoxigenic and nonenterotoxigenic isolates of B. fragilis can be cultured from the feces of diarrheic and healthy individuals. These two groups of B. fragilis are presently indistinguishable from each other by standard in vitro bacteriological procedures and by serological analysis of heat-stable surface antigens (6) . While isolates of nonenterotoxigenic B. fragilis appear to be avirulent for the intestinal tract, isolates of enterotoxigenic B. fragilis may, under the proper conditions, be enteropathogenic in animals and humans. Evidence suggestive of a significant causative role for enterotoxigenic B. fragilis in enteric disease include the common occurrence of enterotoxigenic B. fragilis in diarrheic individuals, the ability of the bacterium to produce an enterotoxin, and the marked enteropathogenicity of the bacterium in rabbit and pig models. We are presently conducting further studies regarding the possible role of enterotoxigenic B. fragilis in the enteric disease complex.
